March 10, 2022 C-Path and Tufts Medical Center Collaborate on EHR Data Transfer The endeavor represents a major milestone for C-Path TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and
March 7, 2022 eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain
March 2, 2022 Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies
March 2, 2022 C-Path Welcomes ActiGraph C-Path is proud to welcome ActiGraph as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compr
March 2, 2022 eCOA Consortium Announces Publication of Open Access Article C-Path’s eCOA Consortium is pleased to announce that “Measurement Comparability of Electronic and Paper Administration of Vi
February 23, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based....
February 6, 2022 View Now: Critical Path to Women Leading in Science Date: Feb 6, 2022 | 1:30 PM Eastern Time (US and Canada) Please join C-Path for a 90-minute roundtable discussing the Critical Pat
February 1, 2022 C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global nonprofit orga
January 31, 2022 The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions
January 19, 2022 Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies